REPORT FINDS PART D EXPLANATIONS CONFUSING
Seniors confusedabout theiroptions underthe new MedicarePart D drugbenefit may notbe getting muchhelp from theexplanations putout by the government'sCenters for Medicare &Medicaid Services (CMS), investigatorswith the congressional GovernmentAccountability Office (GAO) charged.
In a new report on the quality ofinformation put out by CMS to explainPart D, GAO researchers concluded thatthe agency may be leaving manyMedicare recipients confused aboutthe program. The CMS documents preparedto explain the program to seniors"used too much technical jargon andoften did not define difficult terms, suchas formulary," said the GAO officials.
Moreover, whereas 40% of thenation's seniors read at or below the5th-grade level, "the reading levels ofthese [Part D] documents ranged from7th grade to postcollege," the reportsaid. Although the literature producedby CMS to explain the Part D benefitwas "largely complete and accurate," the information "lacked clarity," theGAO investigators said.
Articles in this issue
over 19 years ago
Article
Sexual Dysfunction in Postmenopausal Women: A Focus on Evaluation and TreatmentNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025